Skip to main content
Publications
Kummar S, Shen L, Martinus van Tilburg C, Tan DSW, Doz F, McDermott RS, Zwaan CM, Keating KN, Chirila C , Norenberg R, Fellous MM, Brega N, Xu R, Laetsch TW, Drilon AE, Hong DS. Updated health-related quality of life of patients with TRK-fusion cancer treated with larotrectinib in clinical trials . Poster presented at the 2022 ASCO Annual Meeting; June 3, 2022. Chicago, IL. [abstract] Am J Clin Oncol. 2022 Jun; 40(16_suppl):6563. doi: 10.1200/JCO.2022.40.16_suppl.6563
Rebordosa C , Aguado J , Plana E , Thomas S, Frances A, Lei A, Garcia-Gil E, Nuevo J, Perez-Gutthann S , Castellsague J. Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom . Respir Med. 2019 Jun;152:37-43. doi: 10.1016/j.rmed.2019.04.018
Carsin AE , Fuertes E, Schaffner E, Jarvis D, Anto JM, Heinrich J, Bellisario V, Svanes C, Keidel D, Imboden M, Weyler J, Nowak D, Martinez-Moratalla J, Gullon JA, Sanchez Ramos JL, Caviezel S, Beckmeyer-Borowko A, Raherison C, Pin I, Demoly P, Cerveri I, Accordini S, Gislason T, Toren K, Forsberg B, Janson C, Jogi R, Emtner M, Gomez Real F, Raza W, Leynaert B, Pascual S, Guerra S, Dharmage SC, Probst-Hensch N, Garcia-Aymerich J. Restrictive spirometry pattern is associated with low physical activity levels. A population based international study . Respir Med. 2019 Jan;146:116-23. doi: 10.1016/j.rmed.2018.11.017
Hiligsmann M, Dellaert BG, Dirksen CD, Watson V , Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment . Rheumatology (Oxford). 2017 Jul 1;56(7):1167-76. doi: 10.1093/rheumatology/kex071
Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, de Groot MC, Plana E , Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Huerta C, Alvarez A, de Abajo F, Tauscher M, Hasford J, Fischer R, Reynolds R, Schmiedl S. Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs . Respir Med. 2015 Jul;109(7):828-37. doi: 10.1016/j.rmed.2015.01.010
Rottenkolber M, Rottenkolber D, Fischer R, Ibáñez L, Fortuny J , Ballarin E, Sabaté M, Ferrer P, Thürmann P, Hasford J, Schmiedl S. Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients . Respir Med. 2014 Aug;108(8):1075-90.
Guerra S, Halonen M, Sherrill DL, Venker C, Spangenberg A, Carsin AE , Tares L, Lavi I, Barreiro E, Martinez-Moratalla J, Urrutia I, Sunyer J, Anto JM, Martinez FD. The relation of circulating YKL-40 to levels and decline of lung function in adult life . Respir Med. 2013 Dec;107(12):1923-30. doi: 10.1016/j.rmed.2013.07.013